Holash; Jocelyn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Holash; Jocelyn.The latest application filed is for "methods, compositions, and kits for treatment of cancer".

Company Profile

1.8.14

Holash; Jocelyn - Alameda CA
Holash; Jocelyn - Yonkers NY
Holash; Jocelyn - Amaleda CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods, Compositions, And Kits For Treatment Of Cancer App 20200308286 - Holash; Jocelyn	2020-10-01
Methods, Compositions, And Kits For Treatment Of Cancer App 20180222983 - HOLASH; Jocelyn	2018-08-09
Methods, Compositions, And Kits For Treatment Of Cancer App 20160243228 - HOLASH; Jocelyn ; et al.	2016-08-25
Antitumor Combinations Containing A Vegf-inhibiting Agent And 5fu Or A Derivative Thereof App 20130184205 - Vrignaud; Patricia ; et al.	2013-07-18
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof Grant 8,388,963 - Vrignaud , et al. March 5, 2	2013-03-05
Antitumor Combinations Containing A Vegf-inhibiting Agent And 5fu Or A Derivative Thereof App 20090285841 - VRIGNAUD; Patricia ; et al.	2009-11-19
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent Grant 7,449,182 - Cedarbaum , et al. November 11, 2	2008-11-11
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent App 20080145363 - Cedarbaum; Jesse M. ; et al.	2008-06-19
Method of tumor regression with VEGF inhibitors Grant 7,354,578 - Kandel , et al. April 8, 2	2008-04-08
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent Grant 7,354,581 - Cedarbaum , et al. April 8, 2	2008-04-08
Method of treating cancer with a VEGF antagonist and an anti-proliferative agent Grant 7,354,579 - Holash , et al. April 8, 2	2008-04-08
Use of VEGF antagonists for the treatment of malignant gliomas Grant 7,354,582 - Yung , et al. April 8, 2	2008-04-08
Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF) Grant 7,351,411 - Holash , et al. April 1, 2	2008-04-01
Use of VEGF antagonists for the treatment of malignant gliomas App 20070212354 - Yung; W.K. Alfred ; et al.	2007-09-13
Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF) App 20060210566 - Holash; Jocelyn ; et al.	2006-09-21
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent App 20060183684 - Cedarbaum; Jesse M. ; et al.	2006-08-17
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof App 20060178305 - Vrignaud; Patricia ; et al.	2006-08-10
Use of a VEGF antagonist in combination with radiation therapy App 20050196340 - Holash, Jocelyn ; et al.	2005-09-08
Use of a VEGF antagonist in combination with radiation therapy App 20050112061 - Holash, Jocelyn ; et al.	2005-05-26
Composition of a VEGF antagonist and an anti-proliferative agent App 20050032699 - Holash, Jocelyn ; et al.	2005-02-10
Method of tumor regression with VEGF inhibitors App 20040265309 - Kandel, Jessica ; et al.	2004-12-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.